JPRN-UMIN000007842
Completed
Phase 1
A phase I/II study of concurrent chemoradiotherapy (RT-DeVIC) for newly-diagnosed, localized nasal NK/T-cell lymphoma (JCOG0211-DI) - A phase I/II study of concurrent chemoradiotherapy (RT-DeVIC) for newly-diagnosed, localized nasal NK/T-cell lymphoma (JCOG0211-DI)
Japan Clinical Oncology Group (JCOG)0 sites33 target enrollmentApril 27, 2012
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- extranodal NK/T-cell lymphoma, nasal type
- Sponsor
- Japan Clinical Oncology Group (JCOG)
- Enrollment
- 33
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Clinical symptoms of Central nervous system involvement 2\) Uncontrollable diabetes mellitus 3\) Uncontrollable hypertension 4\) History of myocardial infarction or angina, and/or cardiomyopathy, and/or arrhythmia treated with antiarrhythmic 5\) Positive test for HBs antigen 6\) Positive test for HIV antibody 7\) Interstitial pneumonia, pulmonary fibrosis or severe pulmonary emphysema 8\) Severe infection 9\) Liver cirrhosis 10\) Other active malignancies 11\) Pregnant, possible pregnant, or breastfeeding woman 12\) Use of major tranquilizer, antidepressant, or antimanic 13\) Severe psychosis 14\) Patients or their families, and/or attending physicians hoping hematopoietic stem cell transplantation after obtained responses by RT\-DeVIC
Outcomes
Primary Outcomes
Not specified
Similar Trials
Withdrawn
N/A
A Phase II Study of concurrent chemo-radiotherapy with Gemcitabine followed by chemotherapy with Gemcitabine and Cisplatin for unresectable localized perihilar cholangiocarcinomaNeoplasmsKCT0003478CC Hospital27
Completed
Phase 2
Phase II study of Concurrent Chemoradiotherapy using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma: Kitasato Gynecologic Radiation Oncology Group 0501 (KGROG0501)ocally Advanced Uterine Cervical CarcinomaJPRN-UMIN000025688Kitasato Gynecologic Radiatoin Oncology Group (KGROG)45
Completed
Phase 2
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canalsquamous cell carcinoma of the anal canalJPRN-UMIN000012184Japanese Radiation Oncology Study Group40
Completed
Phase 2
phase II trial of concurrent chemoradiotherapy (CCRT) with docetaxel + cisplatin + cetuximab for locally advanced squamous cell carcinoma of the head and neckadvanced squamous cell carcinoma of the head and neckJPRN-UMIN000013858Department of Biology and Function in the Head and Neck, Yokohama City University Graduate School of Medicine30
Completed
Phase 3
A phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical stage II/III squamous cell carcinoma of the anal canal (JCOG0903, SMART-AC)anal canal canerJPRN-UMIN000003237Japan Clinical Oncology Group(JCOG)71